Supportive Care in Cancer

, Volume 23, Issue 12, pp 3599–3608 | Cite as

Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors: a randomized, wait list controlled pilot study

  • Sally E. Dodds
  • Thaddeus W.W. Pace
  • Melanie L. Bell
  • Mallorie Fiero
  • Lobsang Tenzin Negi
  • Charles L. Raison
  • Karen L. Weihs
Original Article



This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed.


Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a “booster” CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity.


Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity.


Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence.


CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.


Breast cancer Survivorship Meditation Compassion Depression Stress Fear of cancer recurrence 



We extend our deepest gratitude to the breast cancer survivors who participated in this study, to Ole Thienhaus, M.D., Chair of the Department of Psychiatry; to research personnel Laura Eparvier, Martha Barron, Angelica Medrano-Hernandez, and Mary Nielsen; and to Timothy Harrison of the Emory-Tibet Science Initiative without whom this study would not have been possible.

Conflict of interest

The authors declare that they have no competing interests.


  1. 1.
    Thewes B, Brebach R, Dzidowska M, Rhodes P, Sharpe L, Butow P (2014) Current approaches to managing fear of cancer recurrence: a descriptive survey of psychosocial and clinical health professionals. Psycho-Oncology 23:390–396CrossRefPubMedGoogle Scholar
  2. 2.
    Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, Capp A, Dalley D (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 20:2651–2659CrossRefPubMedGoogle Scholar
  3. 3.
    Bleiker EM, Pouwer F, van der Ploeg HM, Leer JW, Ade’r HJ (2000) Psychological distress two years after diagnosis for breast cancer: frequency and prediction. Patient Educ Couns 40:209–217CrossRefPubMedGoogle Scholar
  4. 4.
    Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five-year observational cohort study. BMJ 330:702PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Onc 18:743–743.Google Scholar
  6. 6.
    Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Onc 29:3517–3522CrossRefGoogle Scholar
  7. 7.
    Rokach A (2000) Correlates of loneliness as perceived by the terminally ill. Curr Psychol 19(3):237–248CrossRefGoogle Scholar
  8. 8.
    Rosedale M (2009) Survivor loneliness of women following breast cancer. Onc Nurs Forum 36:175–183CrossRefGoogle Scholar
  9. 9.
    Kabat-Zinn J (1990) Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. Dell Publishing, New YorkGoogle Scholar
  10. 10.
    Carlson LE, Speca M, Patel KD, Goodey E (2003) Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 65:571–581CrossRefPubMedGoogle Scholar
  11. 11.
    Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL (2008) Effect of mindfulness-based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 22:969–981PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Carlson LE, Beattie TL, Giese–Davis J, Faris P, Tamagawa R, Fick LJ, Degelman E, Speca M. (2014) Mindfulness-based cancer recovery and supportive-expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors. Cancer 121:476–484.Google Scholar
  13. 13.
    Ledesma D, Kumano H (2009) Mindfulness-based stress reduction and cancer: a meta-analysis. Psycho Oncology 18:571–579CrossRefPubMedGoogle Scholar
  14. 14.
    Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, Speca M (2013) Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer (MINDSET). J Clin Onc 31:3119–3126CrossRefGoogle Scholar
  15. 15.
    Pinto-Gouveia J, Duarte C, Matos M, Fráguas S (2014) The protective role of self-compassion in relation to psychopathology symptoms and quality of life in chronic and in cancer patients. Clin Psych Psychot 21:311–323CrossRefGoogle Scholar
  16. 16.
    Hall CW, Row KA, Wuensch KL, Godley KR (2013) The role of self-compassion in physical and psychological well-being. J Psychol 147:311–323CrossRefPubMedGoogle Scholar
  17. 17.
    Jazaieri H, Jinpa GT, McGonigal K, Rosenberg EL, Finkelstein J, Simon-Thomas E, Cullen M, Doty JR, Gross JJ, Goldin PR (2013) Enhancing compassion: a randomized controlled trial of a compassion cultivation training program. J Happiness Stud 14:1113–1126CrossRefGoogle Scholar
  18. 18.
    Pace TWW, Negi LT, Adame DD, Cole SP, Sivilli TI, Brown TD, Issa MJ, Raison CL (2009) Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrino 34(1):87–98CrossRefGoogle Scholar
  19. 19.
    Negi LT. (2013) Emory compassion meditation protocol: cognitively-based compassion training manual. Atlanta, Ga., Emory University.Google Scholar
  20. 20.
    Ozawa-de Silva B, Dodson-Lavelle B. (2011) An education of heart and mind: practical and theoretical issues in teaching cognitively-based compassion training to children. Practical Matters 4:1–28, Atlanta, Ga, Emory University.Google Scholar
  21. 21.
    StataCorp. (2013)Stata statistical software: release 13. College Station, TX: StataCorp LP.Google Scholar
  22. 22.
    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396CrossRefPubMedGoogle Scholar
  24. 24.
    Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Measure 1(3):385–401CrossRefGoogle Scholar
  25. 25.
    Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J (1993) Two shorter forms of the CES-D depression symptoms index. J Aging Health. 5:179–193CrossRefPubMedGoogle Scholar
  26. 26.
    Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251CrossRefPubMedGoogle Scholar
  27. 27.
    Weiss DS, Marmar CR (1996) The impact of event scale—revised. In: Wilson J, Keane TM (eds) Assessing psychological trauma and PTSD. Guilford, New York, pp. 399–411Google Scholar
  28. 28.
    Russell D, Peplau LA, Cutrona CE (1980) The Revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Person Soc Psychol 39:472–480CrossRefGoogle Scholar
  29. 29.
    Russell DW (1996) UCLA Loneliness Scale (version 3): reliability, validity, and factor structure. J Personality Assessment 66(1):20–40CrossRefGoogle Scholar
  30. 30.
    Dussault M, Fernet C, Austin S, Leroux M (2009) Revisiting the factorial validity of the Revised UCLA Loneliness Scale: a test of competing models in a sample of teachers. Psychol Rep 105:849–856CrossRefPubMedGoogle Scholar
  31. 31.
    Ware J, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233CrossRefPubMedGoogle Scholar
  32. 32.
    Feldman G, Hayes A, Kumar S, Greeson J, Laurenceau JP (2007) Mindfulness and emotion regulation: the development and initial validation of the Cognitive and Affective Mindfulness Scale-Revised (CAMS-R). J Psychopathol Behav Assess 29:177–190CrossRefGoogle Scholar
  33. 33.
    McCullough ME, Emmons RA, Tsang JA (2002) The grateful disposition: a conceptual an empirical topography. J Person Soc Psychol 82:112–127CrossRefGoogle Scholar
  34. 34.
    Jansen, C, Beunckens, MG, Kenward, C, Mallinckrodt, Carroll, RJ. (2004). Analyzing incomplete longitudinal clinical trial data. Biostatistics 5(3):445–464.Google Scholar
  35. 35.
    Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115:5349–5361CrossRefPubMedGoogle Scholar
  36. 36.
    Pinquart M, Duberstein PR (2010) Depression and cancer mortality: a meta-analysis. Psychol Med 40:1797–1810PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT (2007) Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treatment 105:209–219CrossRefGoogle Scholar
  38. 38.
    Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D (2011) Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Onc 29:413–420CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Sally E. Dodds
    • 1
  • Thaddeus W.W. Pace
    • 2
  • Melanie L. Bell
    • 3
  • Mallorie Fiero
    • 3
  • Lobsang Tenzin Negi
    • 4
  • Charles L. Raison
    • 1
  • Karen L. Weihs
    • 1
  1. 1.University of Arizona College of MedicineTucsonUSA
  2. 2.University of Arizona College of NursingTucsonUSA
  3. 3.University of Arizona Mel and Enid Zuckerman College of Public HealthTucsonUSA
  4. 4.Emory UniversityAtlantaUSA

Personalised recommendations